Clinical Trial Update: The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas [Phase 3]

View source ↗

Summary

A Phase 3 trial update describing SWOAR-sparing IMRT compared with standard IMRT for head and neck squamous cell carcinoma; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Head and Neck Neoplasms, Swallowing Sparing IMRT | Phase 3 | Status: ACTIVE_NOT_RECRUITING